ConductScience.org, home

Paper17519389

Pathobiology of ALK+ anaplastic large-cell lymphoma.

Amin HM and 1 other. Blood, 2007. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Pathobiology of ALK+ anaplastic large-cell lymphoma. Papers, record 17519389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519389

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pathobiology of ALK+ anaplastic large-cell lymphoma.
PubMed
Journal
Blood
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
3.51
iCite
Revised in PubMed
2022-04-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amin HMHesham M
2Lai RRaymond

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphoma, Large-Cell, AnaplasticMajor topic
Protein-Tyrosine KinasesMajor topic
Anaplastic Lymphoma Kinase
Animals
Humans
Protein Binding
Receptor Protein-Tyrosine Kinases
Signal Transduction

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
K08 CA114395NCI NIH HHSUnited StatesK08CA114395PubMed and NIH
CA114395NCI NIH HHSUnited StatesK08CA114395PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References137

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13490284Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy.Blood1986https://conductscience.org/library/papers/3490284PubMed
22914325Major nucleolar proteins shuttle between nucleus and cytoplasm.Cell1989https://conductscience.org/library/papers/2914325PubMed
37889566Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.Cell1995https://conductscience.org/library/papers/7889566PubMed
47718885Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma.Blood1995https://conductscience.org/library/papers/7718885PubMed
58616716Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.Nat Med1996https://conductscience.org/library/papers/8616716PubMed
68633037Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8633037PubMed
78760799Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.J Exp Med1996https://conductscience.org/library/papers/8760799PubMed
89053841Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.Oncogene1997https://conductscience.org/library/papers/9053841PubMed
99057627A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.Blood1997https://conductscience.org/library/papers/9057627PubMed
1011387242The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.FASEB J2001https://conductscience.org/library/papers/11387242PubMed
1111395396The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.Am J Pathol2001https://conductscience.org/library/papers/11395396PubMed
1211448921In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.Clin Cancer Res2001https://conductscience.org/library/papers/11448921PubMed
132917127A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').Br J Haematol1989https://conductscience.org/library/papers/2917127PubMed
142538681Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.Leuk Res1989https://conductscience.org/library/papers/2538681PubMed
152555633The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.Leukemia1989https://conductscience.org/library/papers/2555633PubMed
161465135Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.Nature1992https://conductscience.org/library/papers/1465135PubMed
178491186The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.EMBO J1993https://conductscience.org/library/papers/8491186PubMed
188122112Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.Science1994https://conductscience.org/library/papers/8122112PubMed
198137429The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.Cell1994https://conductscience.org/library/papers/8137429PubMed
2010552961Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.Blood1999https://conductscience.org/library/papers/10552961PubMed

See all 137 referencesDownload CSV of references

Cited by112

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
42631312ALK-negative Anaplastic Large Cell Lymphoma Presenting as Back Pain.J Community Hosp Intern Med Perspect2026https://conductscience.org/library/papers/42631312PubMed
42538745Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK-positive anaplastic large-cell lymphoma.Histopathology2026https://conductscience.org/library/papers/42538745PubMed
42344690Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement.Front Oncol2026https://conductscience.org/library/papers/42344690PubMed
42237783Immune checkpoint therapy in pediatric and adolescent lymphomas.Haematologica2026https://conductscience.org/library/papers/42237783PubMed
40321894A novel clustered-based binary grey wolf optimizer to solve the feature selection problem for uncovering the genetic links between non-Hodgkin lymphomas and rheumatologic diseases.Health Inf Sci Syst2025https://conductscience.org/library/papers/40321894PubMed
39456995Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39456995PubMed
38676786Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.Oncol Ther2024https://conductscience.org/library/papers/38676786PubMed
38650799Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature.Cureus2024https://conductscience.org/library/papers/38650799PubMed
37762644Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma.Int J Mol Sci2023https://conductscience.org/library/papers/37762644PubMed
37425399Patient-led advocacy in ALK-positive lung cancer.Transl Lung Cancer Res2023https://conductscience.org/library/papers/37425399PubMed
37149665New perspectives for targeting therapy in ALK-positive human cancers.Oncogene2023https://conductscience.org/library/papers/37149665PubMed
36591504Current status and challenges of immunotherapy in ALK rearranged NSCLC.Front Oncol2022https://conductscience.org/library/papers/36591504PubMed
36064579ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.Oncogene2022https://conductscience.org/library/papers/36064579PubMed
35954222Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma.Cells2022https://conductscience.org/library/papers/35954222PubMed
35939772Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies.JCO Precis Oncol2022https://conductscience.org/library/papers/35939772PubMed
35836874Primary pulmonary anaplastic large cell lymphoma: case report and literature review.Am J Transl Res2022https://conductscience.org/library/papers/35836874PubMed
34777681Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival.Oxid Med Cell Longev2021https://conductscience.org/library/papers/34777681PubMed
34287231Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter.Curr Issues Mol Biol2021https://conductscience.org/library/papers/34287231PubMed
34043588Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.J Clin Invest2021https://conductscience.org/library/papers/34043588PubMed
33514657Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells.Mol Cancer Res2021https://conductscience.org/library/papers/33514657PubMed

See all 112 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
NPM14869PubTator's text mininghttps://conductscience.org/library/genes/4869NCBI Gene
TNFRSF8943PubTator's text mininghttps://conductscience.org/library/genes/943NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17519389

GET https://conductscience.org/api/papers/v1/17519389/references?page=2